Entitlement Offer Details The Transaction will be partly funded via a 2-for-15 underwritten accelerated renounceable entitlement offer to raise approximately A$401 million at an offer price of A$2.05 per new share (“Entitlement Offer”).The record date under the Entitlement Offer is 7.00pm (AEST) on 29 August 2016 ("Record Date"). The offer price represents a 13.4% discount to the theoretical ex rights price (“TERP”) based on the adjusted last closing price of Evolution on 23 August 2016 11 and a 18.4% discount to TERP based on the adjusted 10 day VWAP of Evolution as at 23 August 2016. 11 The Entitlement Offer comprises an accelerated institutional entitlement offer and a retail entitlement offer. Under the Entitlement Offer, eligible shareholders are invited to subscribe for 2 new fully paid ordinary shares in Evolution ("New Shares") for every 15 existing fully paid ordinary shares in Evolution ("Entitlement") held as at 7.00pm (AEST) on the Record Date.
- Forums
- ASX - By Stock
- EVN
- Trading Halt!
Trading Halt!, page-25
Featured News
Add EVN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.62 |
Change
0.130(2.90%) |
Mkt cap ! $9.190B |
Open | High | Low | Value | Volume |
$4.54 | $4.63 | $4.52 | $40.54M | 8.841M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 99335 | $4.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.62 | 54177 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 99335 | 4.610 |
3 | 98176 | 4.600 |
3 | 210059 | 4.590 |
4 | 48073 | 4.580 |
3 | 31588 | 4.570 |
Price($) | Vol. | No. |
---|---|---|
4.620 | 53321 | 5 |
4.630 | 50000 | 1 |
4.640 | 30478 | 1 |
4.650 | 36946 | 3 |
4.660 | 222781 | 4 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
EVN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online